Sugammadex Injection, Solution
Product Images NDC 71872-7382

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 71872-7382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7382.pdp (7382)

Drug facts panel for Sugammadex Injection 200 mg/2 mL (100 mg/mL) single-dose vial. Includes dosage information, storage instructions, and manufacturer details, indicating it is for intravenous use only and must be protected from light and used within 5 days once opened. The product is supplied as a sterile, non-pyrogenic aqueous solution and repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ.*

FDA Label Image

7382m.pdp (7382m)

Label of Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous solution. The 2 mL single-dose vial label includes dosing information and instructions to peel off and apply to syringe. Manufactured for Somerset Therapeutics, LLC, Somerset, NJ, and made in Germany. Storage and discard instructions are provided.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 01)

Chemical structure of sugammadex, a cyclic oligosaccharide used as the active ingredient in an intravenous injection solution. The diagram displays the molecular structure with sodium carboxylate groups attached to the ring.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 02)

Chemical structure diagram of sugammadex. The image shows the molecular arrangement including rings, hydroxyl groups, sodium carboxylate groups, and sulfur atoms characteristic of sugammadex.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 03)

A line graph comparing cumulative recovery rate over time (in minutes) for sugammadex 2 mg/kg and neostigmine 0.05 mg/kg, both given with rocuronium. The x-axis represents time to recovery (0 to 120 minutes) and the y-axis shows cumulative recovery rate (0 to 1.0). The graph shows faster recovery with sugammadex compared to neostigmine, including median recovery times noted in a legend.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 04)

A cumulative recovery rate chart comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg in patients receiving vecuronium. The x-axis shows time to recovery in minutes (0 to 120), and the y-axis shows cumulative recovery rate (0 to 1). Sugammadex shows a faster and higher recovery rate, nearing complete recovery by 20 minutes. Median recovery times are listed: sugammadex 2.1 minutes, neostigmine 29.0 minutes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.